Structure of human urokinase plasminogen activator in complex with its receptor

被引:256
作者
Huai, Q
Mazar, AP
Kuo, A
Parry, GC
Shaw, DE
Callahan, J
Li, YD
Yuan, C
Bian, CB
Chen, LQ
Furie, B
Furie, BC
Cines, DB
Huang, MD [1 ]
机构
[1] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Div Hemostasis & Thrombosis, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Boston, MA 02215 USA
[3] Attenuon LLC, San Diego, CA 92121 USA
[4] Univ Penn, Med Ctr, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[5] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Peoples R China
[6] Univ Alabama, Struct Biol Lab, Dept Chem, Grad Program Biotechnol, Huntsville, AL 35899 USA
[7] Univ Alabama, Struct Biol Lab, Dept Chem, Grad Program Chem, Huntsville, AL 35899 USA
[8] Univ Alabama, Struct Biol Lab, Dept Chem, Grad Program Mat Sci, Huntsville, AL 35899 USA
[9] DE Shaw Res & Dev, New York, NY 10036 USA
关键词
D O I
10.1126/science.1121143
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The urokinase plasminogen activator binds to its cellular receptor with high affinity and initiates signaling cascades that are implicated in pathological processes including tumor growth, metastasis, and inflammation. We report the crystal structure at 1.9 angstroms of the urokinase receptor complexed with the urokinase amino-terminal fragment and an antibody against the receptor. The three domains of urokinase receptor form a concave shape with a central cone-shaped cavity where the urokinase fragment inserts. The structure provides insight into the flexibility of the urokinase receptor that enables its interaction with a wide variety of ligands and a basis for the design of urokinase-urokinase receptor antagonists.
引用
收藏
页码:656 / 659
页数:4
相关论文
共 23 条
[1]  
Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO
[2]  
2-Z
[3]   The plasminogen activation system in tumor growth, invasion, and metastasis [J].
Andreasen, PA ;
Egelund, R ;
Petersen, HH .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (01) :25-40
[4]   The urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodeling [J].
Behrendt, N .
BIOLOGICAL CHEMISTRY, 2004, 385 (02) :103-136
[5]   uPAR: A versatile signalling orchestrator [J].
Blasi, F ;
Carmeliet, P .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (12) :932-943
[6]   Cancer invasion and tissue remodeling - cooperation of protease systems and cell types [J].
Dano, K ;
Romer, J ;
Nielsen, BS ;
Bjorn, S ;
Pyke, C ;
Rygaard, J ;
Lund, LR .
APMIS, 1999, 107 (01) :120-127
[7]  
ESTREICHER A, 1989, J BIOL CHEM, V264, P1180
[8]   SOLUTION STRUCTURE OF THE AMINO-TERMINAL FRAGMENT OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR [J].
HANSEN, AP ;
PETROS, AM ;
MEADOWS, RP ;
NETTESHEIM, DG ;
MAZAR, AP ;
OLEJNICZAK, ET ;
XU, RX ;
PEDERSON, TM ;
HENKIN, J ;
FESIK, SW .
BIOCHEMISTRY, 1994, 33 (16) :4847-4864
[9]   Epidermal growth factor receptor-dependent and -independent cell-signaling pathways originating from the urokinase receptor [J].
Jo, M ;
Thomas, KS ;
O'Donnell, DM ;
Gonias, SL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) :1642-1646
[10]   THE EFFECT OF ANTISENSE INHIBITION OF UROKINASE RECEPTOR IN HUMAN SQUAMOUS-CELL CARCINOMA ON MALIGNANCY [J].
KOOK, YH ;
ADAMSKI, J ;
ZELENT, A ;
OSSOWSKI, L .
EMBO JOURNAL, 1994, 13 (17) :3983-3991